- Home
- DIAX vs SRDX Comparison
DIAX vs SRDX Comparison
Compare DIAX & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIAX
- SRDX
- Stock Information
- Founded
- DIAX 2005
- SRDX 1979
- Country
- DIAX United States
- SRDX United States
- Employees
- DIAX N/A
- SRDX N/A
- Industry
- DIAX Finance Companies
- SRDX Medical/Dental Instruments
- Sector
- DIAX Finance
- SRDX Health Care
- Exchange
- DIAX Nasdaq
- SRDX Nasdaq
- Market Cap
- DIAX 537.5M
- SRDX 457.0M
- IPO Year
- DIAX N/A
- SRDX 1998
- Fundamental
- Price
- DIAX $14.47
- SRDX $32.37
- Analyst Decision
- DIAX
- SRDX Buy
- Analyst Count
- DIAX 0
- SRDX 3
- Target Price
- DIAX N/A
- SRDX $43.00
- AVG Volume (30 Days)
- DIAX 96.6K
- SRDX 264.6K
- Earning Date
- DIAX 01-01-0001
- SRDX 11-05-2025
- Dividend Yield
- DIAX 7.93%
- SRDX N/A
- EPS Growth
- DIAX N/A
- SRDX N/A
- EPS
- DIAX N/A
- SRDX N/A
- Revenue
- DIAX N/A
- SRDX $120,801,000.00
- Revenue This Year
- DIAX N/A
- SRDX N/A
- Revenue Next Year
- DIAX N/A
- SRDX $3.38
- P/E Ratio
- DIAX N/A
- SRDX N/A
- Revenue Growth
- DIAX N/A
- SRDX N/A
- 52 Week Low
- DIAX $12.80
- SRDX $26.00
- 52 Week High
- DIAX $15.12
- SRDX $40.39
- Technical
- Relative Strength Index (RSI)
- DIAX 42.24
- SRDX 38.89
- Support Level
- DIAX $14.64
- SRDX $31.34
- Resistance Level
- DIAX $14.82
- SRDX $33.17
- Average True Range (ATR)
- DIAX 0.10
- SRDX 0.93
- MACD
- DIAX -0.02
- SRDX -0.34
- Stochastic Oscillator
- DIAX 20.45
- SRDX 22.44
About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.